Anthony Petrone

Mizuho | Healthcare

Anthony Petrone is an analyst from Mizuho specializing in the Healthcare sector. Ranked #1069 out of 4525 analysts, they have issued 50 stock ratings with a success rate of 93.67% and an average return of 15.41%.

Anthony Petrone has a well-established track record, with 50 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 93.67% and an average return of 15.41%, underscoring their expertise and ability to identify winning opportunities for investors.

#1069

Out of 4525

50

Total Ratings

+93.67%

Success Rate

+15.41%

Average Return

Recent Ratings Analysis

EXAS

Jan 20, 2026

Target

$105.00

Current

$102.35

Performance

0.00%

Anthony Petrone rated EXAS as Neutral on Jan 20, 2026, setting a price target of 105. The Hold stance appears justified, as shares hovered around 102.35 with a 0.00% move.

TNDM

Dec 17, 2025

Target

$21.00

Current

$20.49

Performance

-8.61%

On Dec 17, 2025, TNDM was given a Neutral rating by Anthony Petrone, with a target price of 21. The rating provided protection from downside risk as the stock fell to 20.49.

MDXG

Dec 17, 2025

Target

$12.00

Current

$5.39

Performance

-23.98%

MDXG received a Outperform rating from Anthony Petrone on Dec 17, 2025, aiming for 12. The rating hasn’t played out as hoped, with the stock trading 23.98% below expectations.

LNTH

Dec 17, 2025

Target

$72.00

Current

$65.88

Performance

0.98%

On Dec 17, 2025, Anthony Petrone published a Outperform outlook on LNTH, with a target of 72. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 65.88.

LIVN

Dec 17, 2025

Target

$72.00

Current

$62.92

Performance

-0.25%

Anthony Petrone on Dec 17, 2025 assigned LIVN a Outperform rating, with a price target of 72. The recommendation remains pending validation as shares consolidate around 62.92.

INSP

Dec 17, 2025

Target

$130.00

Current

$94.45

Performance

-20.14%

On Dec 17, 2025, Anthony Petrone reaffirmed INSP with a Outperform rating, targeting 130. Shares slid 20.14% despite the recommendation, highlighting downside risks.

GH

Dec 17, 2025

Target

$120.00

Current

$114.87

Performance

17.85%

GH was rated Outperform by Anthony Petrone on Dec 17, 2025, with a price objective of 120. A bullish response from the market helped close the gap of 5.13 to the target.

ESTA

Dec 17, 2025

Target

$90.00

Current

$64.63

Performance

-13.49%

On Dec 17, 2025, Anthony Petrone initiated coverage on ESTA with a Outperform rating and target of 90. The Buy call has yet to be validated as shares remain 25.37 away from the target.

DXCM

Dec 17, 2025

Target

$78.00

Current

$70.73

Performance

7.57%

Anthony Petrone issued a Outperform recommendation for DXCM on Dec 17, 2025, price target set at 78. Investors following the Buy call captured upside momentum, with shares now at 70.73.

HAE

Dec 17, 2025

Target

$90.00

Current

$70.10

Performance

-12.35%

On Dec 17, 2025, HAE was evaluated by Anthony Petrone, who gave a Outperform rating and target of 90. Investors saw limited payoff as shares fell short of the 90 target.

COO

Dec 05, 2025

Target

$100.00

Current

$80.61

Performance

-0.97%

Anthony Petrone rated COO as Outperform on Dec 05, 2025, setting a price target of 100. Shares have remained stable near 80.61, leaving the 100 target still in play.

AXGN

Dec 01, 2025

Target

$40.00

Current

$31.87

Performance

11.71%

On Dec 01, 2025, AXGN was given a Outperform rating by Anthony Petrone, with a target price of 40. The stock rallied 11.71% after the rating, narrowing the gap to the target of 40 and validating the bullish stance.

ALC

Nov 11, 2025

Target

$100.00

Current

$79.06

Performance

2.20%

ALC received a Outperform rating from Anthony Petrone on Nov 11, 2025, aiming for 100. Price action was muted, as shares hovered around 79.06 despite the bullish outlook.

RMD

Oct 31, 2025

Target

$300.00

Current

$253.19

Performance

2.56%

On Oct 31, 2025, Anthony Petrone published a Outperform outlook on RMD, with a target of 300. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 253.19.

EW

Oct 31, 2025

Target

$100.00

Current

$83.46

Performance

1.22%

Anthony Petrone on Oct 31, 2025 assigned EW a Outperform rating, with a price target of 100. The recommendation remains pending validation as shares consolidate around 83.46.

HOLX

Oct 23, 2025

Target

$78.00

Current

$75.11

Performance

1.65%

On Oct 23, 2025, Anthony Petrone reaffirmed HOLX with a Neutral rating, targeting 78. The neutral call matched muted market action of 1.65%.

TFX

Aug 01, 2025

Target

$135.00

Current

$100.34

Performance

-13.42%

TFX was rated Neutral by Anthony Petrone on Aug 01, 2025, with a price objective of 135. Investors who stayed cautious avoided some of the 13.42% decline.

ABT

Jul 18, 2025

Target

$135.00

Current

$121.12

Performance

-2.06%

On Jul 18, 2025, Anthony Petrone initiated coverage on ABT with a Neutral rating and target of 135. The stock’s lack of movement around 121.12 aligned with a cautious approach.

EMBC

Jul 16, 2025

Target

$12.00

Current

$12.29

Performance

26.05%

Anthony Petrone issued a Neutral recommendation for EMBC on Jul 16, 2025, price target set at 12. A neutral call gave way to stronger-than-expected performance, closing in on 12.

STAA

Jul 16, 2025

Target

$18.00

Current

$20.97

Performance

22.70%

On Jul 16, 2025, STAA was evaluated by Anthony Petrone, who gave a Neutral rating and target of 18. Investors who stayed in despite the Hold saw upside of 22.70%.

MDT

Jul 16, 2025

Target

$100.00

Current

$98.60

Performance

9.82%

Anthony Petrone rated MDT as Outperform on Jul 16, 2025, setting a price target of 100. The call has proven timely, with shares rising 9.82% toward the price target of 100.

GKOS

Apr 16, 2025

Target

$175.00

Current

$123.45

Performance

39.02%

On Apr 16, 2025, GKOS was given a Outperform rating by Anthony Petrone, with a target price of 175. The stock rallied 39.02% after the rating, narrowing the gap to the target of 175 and validating the bullish stance.

SENS

Apr 10, 2025

Target

$2.00

Current

$7.10

Performance

-37.83%

SENS received a Outperform rating from Anthony Petrone on Apr 10, 2025, aiming for 2. The rating hasn’t played out as hoped, with the stock trading 37.83% below expectations.

TARS

Mar 06, 2025

Target

$58.00

Current

$70.93

Performance

62.80%

On Mar 06, 2025, Anthony Petrone published a Buy outlook on TARS, with a target of 58. Shares gained 62.80%, underscoring the accuracy of the bullish outlook toward 58.

ADMA

Jun 20, 2024

Target

$14.00

Current

$17.59

Performance

64.24%

Anthony Petrone on Jun 20, 2024 assigned ADMA a Buy rating, with a price target of 14. The Buy call aligned well with market performance, producing a gain of 64.24%.

GEHC

May 01, 2024

Target

$105.00

Current

$78.83

Performance

0.73%

On May 01, 2024, Anthony Petrone reaffirmed GEHC with a Buy rating, targeting 105. Market indecision has kept the 105 target in a holding pattern.

BSX

Apr 25, 2024

Target

$85.00

Current

$91.20

Performance

24.49%

BSX was rated Buy by Anthony Petrone on Apr 25, 2024, with a price objective of 85. A bullish response from the market helped close the gap of -6.20 to the target.

Frequency Asked Questions

Who is Anthony Petrone?

Anthony Petrone is an analyst from Mizuho specializing in the Healthcare sector.

What is Anthony Petrone's success rate?

Anthony Petrone currently has a success rate of +93.67%.

How many ratings has Anthony Petrone issued?

Anthony Petrone has issued 50 stock ratings so far.

What is the average return of Anthony Petrone's calls?

Their stock ratings have generated an average return of +15.41%.

What is Anthony Petrone's ranking?

Anthony Petrone is ranked #1069 out of 4525 analysts.

What types of ratings does Anthony Petrone give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Anthony Petrone?

You can follow Anthony Petrone by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Anthony Petrone?

Their latest rating was a Hold on EXAS issued on 2026-01-20.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep